ADVERTISEMENT

GSK Pharma Q2 Results Review - General Medicines, Specialty, The Key Drivers For Sales Growth: Motilal Oswal

The healthy progress in general medicines and specialty business segments was offset by reduced traction in the vaccines business.

<div class="paragraphs"><p>A GlaxoSmithKline Pharmaceuticals Ltd.'s manufacturing facility. (Source: Company website).</p></div>
A GlaxoSmithKline Pharmaceuticals Ltd.'s manufacturing facility. (Source: Company website).
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More